Gaurav Narula

Employment

• Tata Memorial Centre, Homi Bhabha national Insitute Professor
  2019 - Present
• Tata Memorial Center, Homi Bhabha National Institute Professor Pediatric Oncology & Past Convener Pediatric Hematolymphoid Group
  2016 - Present
• Tata Memorial Centre Associate Professor & Convener Pediatric Hemato- Lymphoid Disease Management Group
  2015 - 2015
• Tata Memorial Centre Associate Professor Pediatric Oncology
  2012 - 2015
• Indian Navy Professor & Classified Specialist Pediatrics & Hematology
  2009 - 2012
• Indian Navy Classified Specialist Pediatrics & Hematologist- Oncologist
  2003 - 2009
• Indian Navy Classified Specialist Pediatrics
  2000 - 2003
• Indian Navy Graded Specialist Pediatrics
  1996 - 2000
• Indian Navy Medical Officer
  1987 - 1995

Education

• Army Hospital - Research and Referral Classification in Hematology
  2009 - 2009
• Tata Memorial Centre Fellowship Pediatric Hematology
  2002 - 2003
• Bai Jerbai Wadia Hospital for Children Fellowship Pediatric Hematology Oncology
  2001 - 2002
• Armed Forces Medical College MD
  1992 - 1995
• National Board of Examinations DNB Pediatrics
  1992 - 1995
• Armed Forces Medical College MBBS
  1983 - 1987

Projects & Funding

Projects & funding information is unavailable.

Publications (123)

• Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)
  The Lancet Regional Health - Southeast Asia 2026 DOI: 10.1016/j.lansea.2026.100788
  +Save
• First clinical experience with 6 Mercaptopurine powder for oral suspension PREVALLTM for maintenance therapy in Pediatric Acute lymphoblastic leukemia
  2026 DOI: 10.22541/authorea.15003115/v1
  +Save
• Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
  Blood 2026 DOI: 10.1182/blood.2025030872
  +Save
• PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia
  JCO Clinical Cancer Informatics 2026 DOI: 10.1200/CCI-25-00222
  +Save
• Growth patterns in children and adolescents treated for acute lymphoblastic leukaemia
  Pediatric Hematology Oncology Journal 2025 DOI: 10.1016/j.phoj.2025.100491
  +Save
• Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.
  Clinical lymphoma, myeloma & leukemia 2025 DOI: 10.1016/j.clml.2025.10.015
  +Save
• Common Variable Immunodeficiency Disorder: A Decade of Insights from a Cohort of 150 Patients in India and the Use of Machine Learning Algorithms to Predict Severity.
  Journal of clinical immunology 2025 DOI: 10.1007/s10875-025-01897-9
  +Save
• Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for India.
  Ecancermedicalscience 2025 DOI: 10.3332/ecancer.2025.1931
  +Save
• Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India
  The Lancet Regional Health - Southeast Asia 2025 DOI: 10.1016/j.lansea.2025.100593
  +Save
• Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
  Blood Cancer Journal 2025 DOI: 10.1038/s41408-025-01308-7
  +Save